Coxsackievirus B infection and pathogenesis of type 1 diabetes

Nekoua, Magloire Pandoua; Mercier, Ambroise; Vergez, Inès; Morvan, Corentin; Mbani, Chaldam Jespere; Sané, Famara; Lobert, Delphine; Romond, Marie-Bénédicte; Alidjinou, Enagnon Kazali; Hober, Didier

doi:10.1684/vir.2022.0976

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This virus transmits quickly from one person to another, generally by direct contact or contact with feces-contaminated surfaces. Because the virus can survive without a host for several days, propagating is very simple [ 10 – 12 ].…”

Section: Introductionmentioning

confidence: 99%

A computational approach to fighting type 1 diabetes by targeting 2C Coxsackie B virus protein with flavonoids

Ullah,

Zheng,

Rahman

et al. 2023

PLoS ONE

View full text Add to dashboard Cite

Autoimmune diabetes, well-known as type 1 insulin-dependent diabetic mellitus (T1D). T1D is a prolonged condition marked by an inadequate supply of insulin. The lack is brought on by pancreatic cell death and results in hyperglycemia. The immune system, genetic predisposition, and environmental variables are just a few of the many elements that contribute significantly to the pathogenicity of T1D disease. In this study, we test flavonoids against Coxsackie virus protein to cope the type 1 diabetes. After protein target identification we perform molecular docking of flavonoids and selected target (1z8r). then performed the ADMET analysis and select the top compound the base of the docking score and the ADMET test analysis. Following that molecular dynamics simulation was performed up to 300 ns. Root means square deviation, root mean square fluctuation, secondary structure elements, and protein-ligand contacts were calculated as post-analysis of simulation. We further check the binding of the ligand with protein by performing MM-GBSA every 10 ns. Lead compound CID_5280445 was chosen as a possible medication based on analysis. The substance is non-toxic, meets the ADMET and BBB likeness requirements, and has the best interaction energy. This work will assist researchers in developing medicine and testing it as a treatment for Diabetes Mellitus Type 1 brought on by Coxsackie B4 viruses by giving them an understanding of chemicals against these viruses.

show abstract

Section: Introductionmentioning

confidence: 99%